Detalhe da pesquisa
1.
Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof-of-Principle Issues from a Randomized Controlled Study.
Mov Disord
; 37(7): 1516-1525, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35607776
2.
Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study.
BMC Neurol
; 17(1): 129, 2017 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28676085
3.
A comprehensive review of spinocerebellar ataxia type 2 in Cuba.
Cerebellum
; 10(2): 184-98, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21399888
4.
Oral zinc sulphate supplementation for six months in SCA2 patients: a randomized, double-blind, placebo-controlled trial.
Neurochem Res
; 36(10): 1793-800, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21562746
5.
Treatment with nasal neuro-EPO improves the neurological, cognitive, and histological state in a gerbil model of focal ischemia.
ScientificWorldJournal
; 10: 2288-300, 2010 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-21103798
6.
Detection of a nonerythropoietic erythropoietin, Neuro-EPO, in blood after intranasal administration in rat.
Drug Test Anal
; 12(11-12): 1605-1613, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32856413
7.
The nasal route as a potential pathway for delivery of erythropoietin in the treatment of acute ischemic stroke in humans.
ScientificWorldJournal
; 9: 970-81, 2009 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19768354
8.
Changes in the expression level of MAPK pathway components induced by monosodium glutamate-administration produce neuronal death in the hippocampus from neonatal rats.
Neuroscience
; 365: 57-69, 2017 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28954212
9.
An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
J Alzheimers Dis
; 55(1): 231-248, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27662300
10.
Neuroprotective effect of Neuro-EPO in neurodegenerative diseases: "Alea jacta est".
Neural Regen Res
; 14(9): 1519-1521, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31089047
11.
Campo magnético de frecuencia extremadamente baja: Seguridad de su aplicación a nivel del sistema nervioso central / Magnetic field of extremely low frequency: Safety of its application at the level of the central nervous system
Rev. cuba. invest. bioméd
; 37(2): 75-86, abr.-jun. 2018. ilus
Artigo
em Espanhol
| LILACS, CUMED | ID: biblio-1003928
12.
Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aß25â35 non-transgenic mouse model of Alzheimer's disease.
J Psychopharmacol
; 27(11): 1044-57, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23813967
13.
Oxidative stress as a cofactor in spinocerebellar ataxia type 2.
Redox Rep
; 17(2): 84-9, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22564351
14.
Neuroquímica de la esquizofrenia: bases para una nueva teoría / Neurochemistry of the schizophrenia: bases of the new theory
Rev. Hosp. Psiquiátr. La Habana
; 2(1)2005. tab
Artigo
em Espanhol
| LILACS | ID: lil-412746